感染性休克患者血管加压素血浆浓度及临床相关因素的分析
被引量:3
摘要
感染性休克患者常存在顽固性低血压及儿茶酚胺类药物抵抗现象,导致其治疗困难及高死亡率。理论上,在感染性休克患者中血管加压素(arginine-vasopressin,AVP)能发挥有效的缩血管作用。
出处
《临床麻醉学杂志》
CAS
CSCD
北大核心
2011年第9期921-922,共2页
Journal of Clinical Anesthesiology
参考文献6
-
1Leone M, Albanese J, Delmas A, et al. Terlipressin in cate- cholamine resistant septic shock patients. Shock, 2004, 22: 314-319.
-
2Mutlu GM, Factor P. Role of vasopressin in the management of septic shock. Intensive Care Med, 2004, 30: 1276-1291.
-
3Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med, 2008, 358:877- 887.
-
4Maxime V, Siami S, Annane D. Metabolism modulators in sepsis: the abnormal pituitary response. Crit Care Med, 2007, 35: S596-601.
-
5O' Brien AJ, Thakur G, Buckley JF, et al. The pore-forming subunit of the K(ATP) channel is an important molecular tar- get for LPS-induced vascular hyporeactivity in vitro. Br J Pharmacol, 2005, 144:367 -375.
-
6周晓敏,薛张纲,葛圣金.小剂量精氨酸加压素在血管扩张性休克病人中的应用[J].临床麻醉学杂志,2007,23(11):885-887. 被引量:1
二级参考文献7
-
1Malay MB, Ashton JL, Dahl K, et al. Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock. Crit Care Med, 2004,32:1327-1331.
-
2Holmes CL, Patel BM, Russell JA, et al. Physiology of vasopressin relevant to management of septic shock. Chest, 2001,120: 989-1002.
-
3Mutlu GM, Factor P. Role of vasopressin in the management of septic shock. Intensive Care Med, 2004,30 : 1276-1291.
-
4Jochberger S, Mayr VD, Luckner G, et al. Serum vasopressin concentrations in critically ill patients. Crit Care Med, 2006,34 : 293-299.
-
5Dunser MW, Mayr AJ, Tur A, et al. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamineresistant vasodilatory shock: incidence and risk factors. Crit Care Med, 2003,31 : 1394-1398.
-
6Wiesenac kC, Prasser C, Rodig G, et alo Stroke volume variation as an indicator of fluid responsiveness using pulse contour analysis in mechanically ventilated patients. Anesth Analg, 2003,96: 1254-1257.
-
7王毅伟,朱玉琦,赵金英,林世升,张利军.失血性休克患者血浆肾上腺髓质素与血管阻力变化的关系[J].临床麻醉学杂志,2002,18(5):248-249. 被引量:3
同被引文献30
-
1赵会新,乔宠,高嵩,王永来.腹腔镜下子宫肌壁间肌瘤核除术中应用垂体后叶素的临床效果分析[J].实用药物与临床,2007,10(2):69-70. 被引量:20
-
2Kamisago M,Sharma SD,DePalma SR,Solomon S,Sharma P,McDonough B,et al.Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy[J].N Engl J Med,2000,343:1 688-1 696.
-
3Morimoto S.Sarcomeric proteins and inherited cardiomyopathies[J].Cardiovasc Res,2008,77:659-666.
-
4Sahn DJ,Demaria A,Kisslo J,et al.Recommendations regarding quantitation inM-modeechocardiography:results of asurvey of echocardiographicmeasurements[J].Circulation,1978,58:1 072.
-
5OcBrien AJ,Thakur G,Buckley JF,et al.Thepore-forming subunit of theK (ATP) channelis animportant molecular tar-get for LPS-induced vascular hyporeactivity in vitro[J].Br J Pharmacol,2005,144:367-375.
-
6Nguyen T,Pei R,Landry DW,et al.Microfluidic aptameric affinity sensing of vasopressin for clinical diagnostic and therapeutic applications[J].Sensors and Actuators B Chemical,2011,154(1):59-66.
-
7Bauer SR,Culver DA,Abraham S,et al.Detectability of vasopressin in continuous venovenous hemodialysis effluent of patients with vasodilatory shock treated with exogenous arginine vasopressin.[J].Pharmacotherapy,2011,31(9):857-862.
-
8Treschan TA.Peters J.The vasopressin System:physiology and clinical strategies[J].Anesthesiology,2006,105(3):599-612.
-
9王美兰,顾平,陶海燕,陆玉梅,张琳.垂体后叶素在难治性感染性休克中应用的护理[J].中华护理杂志,2008,43(10):904-905. 被引量:5
-
10邓振忠,赵允召.去甲肾上腺素在脓毒症休克中的应用进展[J].医学研究生学报,2009,22(3):311-314. 被引量:7
引证文献3
-
1王海鹏,屈百鸣,赵丽,张健.心肌1号对异丙肾上腺素心肌损伤大鼠的左室舒张末径与射血分数的影响[J].江西中医学院学报,2012,24(6):67-70.
-
2王忠和,陈建朋,胡湘福,尤胜张,叶星海.垂体后叶素在脓毒性休克治疗中的应用[J].实用药物与临床,2013,16(12):1179-1182. 被引量:2
-
3李海,张海波,宋玲莉,韩明.小剂量血管加压素对感染性休克患者血乳酸及肾衰竭进展影响的研究[J].中国急救医学,2018,38(8):695-699. 被引量:5
二级引证文献7
-
1朱红阳,徐晓,倪红英,章仲恒,邓鸿胜,朱莉.小剂量垂体后叶素对脓毒性休克患者心肺损伤指标及组织灌注和氧代谢指标的影响[J].中国中西医结合急救杂志,2014,21(5):376-381. 被引量:12
-
2赵广明,郭海洋,钟磊,王焱琳,柳知含,胡占升.特利加压素联合去甲肾上腺素对感染性休克大鼠急性肝损伤的影响[J].中国急救医学,2019,39(3):274-279. 被引量:8
-
3曾廷武,邹玉刚,马万宇,刘龙.去甲肾上腺素联合垂体后叶素对老年感染性休克患者器官功能的影响[J].中国老年学杂志,2020,40(15):3284-3287. 被引量:9
-
4李秋红.小剂量血管加压素联合去甲肾上腺素对感染性休克患者血流动力学及肾功能的影响[J].现代医学与健康研究电子杂志,2021,5(1):69-71. 被引量:1
-
5马春燕,于苏淮.重症感染性休克患者去甲肾上腺素联合纳洛酮治疗对CI、MAP、CVP、SpO_(2)、SvO_(2)的影响[J].检验医学与临床,2021,18(13):1904-1907. 被引量:13
-
6李艳秀,朱恩泽,周春雷,刘云,左祥荣,李京杭,曹权.血管加压素与重症患者预后的相关性研究[J].内科理论与实践,2021,16(3):183-187.
-
7陈端扬,郑福珍.肾上腺素与血管加压素联合心肺复苏治疗心源性猝死患者的疗效[J].深圳中西医结合杂志,2021,31(23):119-121. 被引量:1
-
1李志平,范士志,蒋耀光,王如文,陈建明,牛会军,何勇,郭伟,沈诚.风心病合并肺动脉高压体外循环后前列腺素E_1抵抗现象的研究[J].第三军医大学学报,2007,29(9):792-795. 被引量:3
-
2赖济环,蔡硕豪,崔志谦,梁色明.胆囊切除术后综合征临床相关因素分析与预防[J].岭南现代临床外科,2010,10(3):191-192.
-
3王勇,屠苏,孙凯,徐鑫荣.儿茶酚胺类药物对内毒素休克兔心肌的影响[J].江苏医药,2005,31(7):524-526. 被引量:3
-
4薛培丽,高占成.尿毒症肺临床相关因素的研究[J].职业卫生与病伤,2004,19(4):252-254. 被引量:3
-
5杨珉,马行一,舒贝,栾森,曾燕.老年与非老年肾小管酸中毒患者临床相关因素对比分析[J].中国老年学杂志,2006,26(12):1622-1624. 被引量:3
-
6张燕,陈卫东.原发性肾病综合征并发急性肾衰18例因素分析[J].实用全科医学,2005,3(5):399-400. 被引量:4
-
7张翠兰.174例小儿烧伤相关因素分析[J].中国现代药物应用,2010,4(16):63-64.
-
8张静,张兴华.全髋关节置换术中骨水泥致顽固性低血压72h一例[J].中国骨与关节损伤杂志,2008,23(12):982-982. 被引量:2
-
9董威,王立强,李太伦.地塞米松在显微外科麻醉中的应用体会[J].现代中西医结合杂志,2006,15(4):513-513.
-
10吴艳.择期冠状动脉介入术后氯吡格雷抵抗现象的临床观察[J].当代医学,2013,19(35):126-126. 被引量:2